Lensar (LNSR) Amortizatization of Intangibles (2024 - 2025)

Lensar's (LNSR) quarterly Amortizatization of Intangibles came in at $18000.0 in Q4 2025, down 72.31% year-on-year from $65000.0 in Q4 2024, and down 72.31% on a QoQ basis from $65000.0 in Q3 2025.

Lensar (LNSR) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

Lensar (LNSR) has 2 years of Amortizatization of Intangibles data on file, last reported at $18000.0 in Q4 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 72.31% year-over-year to $18000.0 in Q4 2025; TTM through Dec 2025 was $181000.0, a 27.6% decrease from a year earlier, with the FY2025 full-year figure at $181000.0, down 27.6% from the prior year.
  • Amortizatization of Intangibles for Q4 2025 stood at $18000.0, down from $65000.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for LNSR reached as high as $69000.0 in Q2 2024 and fell as low as $18000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn -
10 Lensar 65.43 Mn 54.33 Mn 6.38 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 18,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 65,000.00
Sep 30, 2025 65,000.00
Jun 30, 2025 51,000.00
Jun 30, 2025 51,000.00
Mar 31, 2025 47,000.00
Mar 31, 2025 47,000.00
Dec 31, 2024 65,000.00
Dec 31, 2024 65,000.00
Sep 30, 2024 65,000.00
Sep 30, 2024 65,000.00
Jun 30, 2024 69,000.00
Jun 30, 2024 69,000.00
Mar 31, 2024 51,000.00
Mar 31, 2024 51,000.00